Jinhai Medical Technology (HKG:2225) appointed He Xiao as the chief of marketing officer of the group with effect from Oct. 1, for an initial term of three years, a Friday filing with the Hong Kong Exchange said.
He Xiao will be responsible for formulating and implementing marketing strategies, sales targets, sales channel promotion, and management along with overseeing the sales and marketing functions of the group.
Price (HKD): $6.05, Change: $+0.020, Percent Change: +0.33%
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments